Format

Send to:

Choose Destination

Links from GEO Profiles

Full record GDS3044

Imatinib effect on K562 leukemia cell line (III)

Analysis of K562 leukemia cells treated with 1 uM imatinib for 24 hours. Imatinib is a highly selective and potent growth-inhibitor of BCR/ABL1 expressing cells such as K562. Results provide insight into molecular mechanisms underlying BCR/ABL1-mediated leukemogenesis.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 2 agent sets
Platform:
GPL96
Series:
GSE1922
6 Samples
Download data: CEL
DataSet
Accession:
GDS3044
ID:
3044

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center